Issued Patents All Time
Showing 1–25 of 32 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12059454 | Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders | Qiuhong Li, Mohan K. Raizada | 2024-08-13 |
| 11332754 | Codon optimization for increasing transgene expression in chloroplasts of higher seed plants | — | 2022-05-17 |
| 11246819 | Compositions and methods for inhibiting biofilm deposition and production | Hyun Koo | 2022-02-15 |
| 11241487 | Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders | Qiuhong Li, Mohan K. Raizada | 2022-02-08 |
| 11007247 | Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers | — | 2021-05-18 |
| 10889825 | Compositions and methods thereof for down-regulation of genes following oral delivery of an RNAi molecule bioencapsulated within plant cells | — | 2021-01-12 |
| 10865419 | Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes | — | 2020-12-15 |
| 10806775 | Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertensions, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders | — | 2020-10-20 |
| 10752909 | Chloroplasts engineered to express pharmaceutical proteins in edible plants | — | 2020-08-25 |
| 10689633 | Expression of β-mannanase in chloroplasts and its utilization in lignocellulosic woody biomass hydrolysis | — | 2020-06-23 |
| 10676751 | Production and use of plant degrading materials | — | 2020-06-09 |
| 10556932 | Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients | Roland Herzog | 2020-02-11 |
| 10314893 | Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders | Qiuhong Li, Mohan K. Raizada | 2019-06-11 |
| 10233216 | Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients | Roland Herzog | 2019-03-19 |
| 9885055 | Chloroplasts engineered to express pharmaceutical proteins | — | 2018-02-06 |
| 9724400 | Administration of plant expressed oral tolerance agents | Roland Herzog | 2017-08-08 |
| 9657302 | Expression of human interferon in transgenic chloroplasts | — | 2017-05-23 |
| 9605045 | Expression of the human IGF-1 in transgenic plastids | — | 2017-03-28 |
| 7803991 | Universal chloroplast integration and expression vectors, transformed plants and products thereof | — | 2010-09-28 |
| 7795497 | Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection | — | 2010-09-14 |
| 7767885 | Plastid genetic engineering via somatic embryogenesis | — | 2010-08-03 |
| 7741536 | Expression of human serum albumin in plastids | — | 2010-06-22 |
| 7354760 | Expression of protective antigens in transgenic chloroplasts | — | 2008-04-08 |
| 7329802 | Genetic engineering of cotton to increase fiber strength, water absorption and dye binding | — | 2008-02-12 |
| 7294506 | Tobacco chloroplast transformation vectors comprising a multi-gene operon encoding a biopharmaceutical protein and a chaperonin | William Moar | 2007-11-13 |